Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation

Clinics in Chest Medicine(2022)10.1016/j.ccm.2022.06.007Source: DataRank Database

The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation is a research paper published in Clinics in Chest Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 60 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access60 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: greenTopics (14)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Sebastián A. Riquelme ORCID,Katherine B. Hisert ORCID,Lindsay J. Caverly ORCID

Live enrichment

PubMed:36344072 PMC:PMC10224747

Cystic Fibrosis Foundation

Grant: RIQUEL21I0

Cystic Fibrosis Foundation

Grant: 1R35HL135800

Cystic Fibrosis Foundation

Grant: K08 HL136786

Cystic Fibrosis Foundation

Grant: HISERT19R3

Cystic Fibrosis Foundation

Grant: CAVERL20Y5

Cystic Fibrosis Foundation

Grant: HISERT20A0

Cystic Fibrosis Foundation

Grant: PG010094

NIH

Grant: K23HL136934

NHLBI NIH HHS

Grant: R35 HL135800

Vertex Pharmaceuticals Inc

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10224747/pdf/nihms-1897892.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0272523122000685?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0272523122000685?httpAccept=text/plain

MeSH Terms

HumansCystic FibrosisInflammationAminophenolsQuinolonesCystic Fibrosis Transmembrane Conductance RegulatorMutationQuality of Life

Keywords

InfectionInflammationModulatorCystic FibrosisCystic Fibrosis Transmembrane RegulatorHighly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy (Hemt)